Experts query case for GlaxoSmithKline's new 3-in-1 lung drug Ruby Khatun Khatun22 April 2018 9:45 AM ISTLONDON: Two medical experts have urged caution in using a new three-in-one inhaler for chronic lung disease from GlaxoSmithKline, which the company...
Abbott sticks to earlier forecasts, disappoints investors Ruby Khatun Khatun22 April 2018 9:30 AM ISTAbbott Laboratories' just beat expectations for first-quarter profits and revenue but stuck to a full-year profit forecast some investors had expected...
Cognizant completes acquisition of Bolder Healthcare Solutions Ruby Khatun Khatun21 April 2018 11:00 AM ISTNew Delhi: IT firm Cognizant said it has completed the acquisition of Bolder Healthcare Solutions, a provider of revenue cycle management (RCM)...
P&G to acquire 51.8 percent stake in Merck in India for Rs 1,290 crore Ruby Khatun Khatun21 April 2018 10:30 AM ISTNew Delhi: Procter & Gamble (P&G) will acquire 51.80 percent stake for Rs 1,289.88 crore in India listed drug firm Merck Ltd as part of a...
Zydus gets USFDA nod for drug used treat knee osteoarthritis Ruby Khatun Khatun21 April 2018 10:15 AM ISTNew Delhi: Zydus Cadila has received final approval from the US health regulator to market Diclofenac Sodium Topical Solution, used for treating signs...
AstraZeneca wins US approval for 1st-line use of lung cancer drug Ruby Khatun Khatun21 April 2018 9:45 AM ISTU.S. regulators have expanded use of AstraZeneca’s lung cancer drug Tagrisso to include initial treatment of patients with a specific genetic...
GSK flags pharma Merger and Acquisition ambitions by poaching Roche deal-maker Ruby Khatun Khatun21 April 2018 9:30 AM ISTLONDON: GlaxoSmithKline (GSK) signaled its intention to boost its drug pipeline through deals on Wednesday by hiring Kevin Sin from Roche’s Genentech...
Fortis Update: Radiant makes offer, Fortis forms new panel to decide proposals Ruby Khatun Khatun20 April 2018 3:32 PM ISTNew Delhi: With four suitors in race, Fortis Healthcare board approved evaluation of only binding offers and formed an expert committee to evaluate...
Glenmark gets USFDA nod for skin ointment Ruby Khatun Khatun20 April 2018 10:30 AM ISTNew Delhi: Glenmark Pharmaceuticals has received final approval from the US health regulator for Tacrolimus ointment used for treating atopic...
Rs 621 crore bank fraud: 3 pharma firm directors booked Ruby Khatun Khatun20 April 2018 10:15 AM ISTNew Delhi: The CBI has registered a case against Surya Pharmaceuticals, its directors and officials of three companies based in Dubai and Patiala for...
Novo Nordisk, Red Cross team up to tackle chronic diseases in conflict zones Ruby Khatun Khatun20 April 2018 9:45 AM ISTCOPENHAGEN: Danish drugmaker Novo Nordisk and aid agency Red Cross have teamed up to try to improve the treatment of chronic diseases among the...
Roche's Hemlibra gets speedy FDA review for wider use Ruby Khatun Khatun20 April 2018 9:30 AM ISTZURICH: Roche’s hemophilia A drug Hemlibra will get an accelerated review by U.S. regulators for use in a new group of patients, a key part of the...
